Evidence map›Paper›PMID 31849919›Full record

ReviewFrontiers in microbiology2019

Review on Antifungal Resistance Mechanisms in the Emerging Pathogen

Farid Chaabane, Artan Graf, Léonard Jequier, Alix T Coste

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed.

  1. Changes in Epidemiology of Candidemia in the United States With a Focus on Candida auris.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  2. Multicenter performance evaluation of the SimplexaJournal of clinical microbiology · 2026
    Article
  3. Beyond intrinsic resistance: novel insights into the emergence and management of resistance acquired in Candida auris upon antifungal exposure.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Journal of fungi (Basel, Switzerland) · 2026
    Review
  11. Mortality ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  12. Review
  13. Review
  14. Genomic Insights intoJournal of fungi (Basel, Switzerland) · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Antifungal activity of cephalosporins as an alternative for the combat of Candida auris.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Farid ChaabaneSchool of Biology, University of Lausanne, Lausanne, Switzerland.
Artan GrafSchool of Biology, University of Lausanne, Lausanne, Switzerland.
Léonard JequierSchool of Biology, University of Lausanne, Lausanne, Switzerland.
Alix T CosteInstitute of Microbiology, University Hospital (CHUV), Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antifungal resistancebiofilmCandida aurisemerging pathogenMICoutbreaks

Identifiers

PMID31849919
PMCPMC6896226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.